The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConcurrent Technologies Regulatory News (CNC)

Share Price Information for Concurrent Technologies (CNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 97.00
Bid: 95.00
Ask: 99.00
Change: 2.00 (2.11%)
Spread: 4.00 (4.211%)
Open: 95.00
High: 97.00
Low: 95.20
Prev. Close: 95.00
CNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Product Announcement

2 Mar 2017 10:11

RNS Number : 3523Y
Concurrent Technologies PLC
02 March 2017
 

 

02 March 2017

Concurrent Technologies Plc

('Concurrent Technologies' or the 'Company')

 

Product Announcement 

Latest VPXproduct designed for the rugged server markets

 

Concurrent Technologies Plc (AIM: CNC), a world leading specialist in the design and manufacture of high-end, embedded computer boards for critical applications, is pleased to announce a further addition to its increasing range of VPX™ boards, the TR G4x/msd.

 

This high performance processor board is based on the Intel® Xeon® Processor combined with up to 64GB of memory, doubling the previous maximum capacity of memory on boards within this product family. This key benefit, and the enhanced storage options provided on this product, will particularly appeal to designers of systems within the embedded rugged server defence markets. These markets require the highest performance products available but are constrained by maximum size, weight and power limits due to the nature of the harsh, often mobile or remote, environments in which they are deployed.

 

This board, as with all Concurrent Technologies products, is a long life-cycle product available in both commercial and, later this year, rugged variants.

 

Glen Fawcett, CEO, Concurrent Technologies, commented:

"Battlefield communication and surveillance systems require the performance of large servers but contained in smaller, portable, and more rugged chassis. This latest product is an ideal candidate for such applications and will combine very well with our complementary switches and I/O products, to meet the demanding needs of this defence market sector. With major defence budgets predicted to rise, requirements for such applications can be expected to increase."

 

 

Enquiries:

Concurrent Technologies PlcGlen Fawcett, CEO

 

+44 (0)1206 752 626

Newgate (Financial PR)Bob Huxford

James Browne

+44 (0)207 653 9850

Cenkos Securities plc (NOMAD)Neil McDonald

Nick Tulloch

Beth McKiernan

+44 (0)131 220 9771

+44 (0)131 220 9772

+44 (0)131 220 9778

 

Note to Editors:

 

About Concurrent Technologies Plc

 

Concurrent Technologies Plc develops and manufactures high-end embedded computer products for use in a wide range of high performance, long life cycle applications within the telecommunications, defence, security, telemetry, scientific and aerospace markets, including applications within extremely harsh environments. The processor products traditionally feature Intel® processors, including the latest generation Intel® Core™ i7 processors, Intel® Xeon® and Intel® Atom™ processors. More recently NVIDIA® Tegra® K1 devices have been added to the product ranges along with complementary switch and I/O boards. The products are designed to be compliant with industry specifications and support many of today's leading embedded Operating Systems. The products are sold world-wide.

 

For more information on Concurrent Technologies Plc and its products please visit www.cct.co.uk.

 

All trademarks, registered trademarks and trade names used in this announcement are the property of their respective owners.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBGGDXIGGBGRD
Date   Source Headline
29th Mar 20174:33 pmRNSHolding(s) in Company
24th Mar 20177:00 amRNSFinal Results
22nd Mar 20177:00 amRNSNotice of Results
2nd Mar 201710:11 amRNSProduct Announcement
24th Feb 20177:00 amRNSSecond Interim Dividend
30th Jan 20179:23 amRNSProduct Announcement
13th Jan 20179:30 amRNSHolding(s) in Company
13th Jan 20179:30 amRNSHolding(s) in Company
20th Dec 20162:36 pmRNSPre-Close Trading Update
16th Dec 20163:13 pmRNSDirector/PDMR Shareholding
1st Nov 20167:00 amRNSProduct Launch
29th Sep 20167:00 amRNSProduct Launch
22nd Sep 20162:45 pmRNSTotal Voting Rights
9th Sep 201612:05 pmRNSDirector/PDMR Shareholding
30th Aug 20165:05 pmRNSHolding(s) in Company
30th Aug 201612:59 pmRNSHolding(s) in Company
26th Aug 20167:00 amRNSInterim Results
19th Aug 20162:21 pmRNSNotice of Interim Results
22nd Jul 20161:55 pmRNSHolding(s) in Company
1st Jul 20167:00 amRNSTrading Update
1st Jun 20162:43 pmRNSTotal Voting Rights
19th May 201612:56 pmRNSAGM Statement
12th May 20165:18 pmRNSDirector/PDMR Shareholding
6th May 20167:00 amRNSProduct Launch
19th Apr 20163:51 pmRNSDirector/PDMR Shareholding
19th Apr 201612:10 pmRNSDirector/PDMR Shareholding
18th Apr 20162:14 pmRNSDirector/PDMR Shareholding
18th Apr 201610:55 amRNSPosting of Annual Report & Accounts
29th Mar 20164:53 pmRNSHolding(s) in Company
24th Mar 201612:55 pmRNSHolding(s) in Company
21st Mar 20163:20 pmRNSHolding(s) in Company
18th Mar 20167:00 amRNSResults for the year ended 31 December 2015
14th Mar 201612:20 pmRNSNotice of Results
19th Jan 201610:18 amRNSProduct Launch
23rd Dec 20159:59 amRNSDirector/PDMR Shareholding
16th Dec 20153:22 pmRNSPre-Close Trading Update
19th Nov 20152:19 pmRNSDirector/PDMR Shareholding
10th Nov 20157:00 amRNSProduct Launch
20th Oct 201511:35 amRNSTotal Voting Rights
14th Oct 20151:00 pmRNSProduct Launch
15th Sep 20152:09 pmRNSTransaction in Own Shares
14th Sep 20154:59 pmRNSTransaction in Own Shares
2nd Sep 20159:05 amRNSProduct Update
2nd Sep 20157:00 amRNSHalf Yearly Report
19th Aug 201511:13 amRNSNotice of Interim Results
27th May 20154:08 pmRNSResult of AGM
26th May 201512:37 pmRNSAGM Statement
21st May 20157:00 amRNSTrading Update
5th May 201510:40 amRNSPosting of Annual Report & Accounts
9th Apr 20154:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.